Press Release Distribution
anda Latest News+ XML/RSS
By SMi Group
The state of the European generics market, how will your company make a profit?
This 3-hr virtual seminar on the FDA New Drug Approval Process will cover the NDA and ANDA review and approval process including a discussion of preparing NDAs and ANDAs, relevant meetings, timing, costs, approval requirements.
By Mission3, Inc.
Mission3, Inc., a leading provider of program delivery for the Life Sciences industry, announced today that a leading generics pharmaceutical has successfully compiled and submitted a pair of ANDAs to the FDA using Mission3 OnDemand.
By Justin Handy
PennyToBuck Update On WCRX, DTPI and CRWE For August 23rd, 2010.